Citation Impact
Citing Papers
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Endothelial Dysfunction, Oxidative Stress, and Risk of Cardiovascular Events in Patients With Coronary Artery Disease
2001 Standout
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
Relationship between insulin resistance and cardiac sympathetic nervous function in essential hypertension
1999
Reduction of Sympathetic Hyperactivity by Enalapril in Patients with Chronic Renal Failure
1999
Cardiac Disease in Chronic Uremia: Pathophysiology
1997
Compensated cardiac hypertrophy: arrhythmogenicity and the new myocardial phenotype. I. Fibrosis
1997
Left ventricular growth response to exercise and cigarette smoking: data from LARGE Heart
2006
The Failing Heart — An Engine Out of Fuel
2007 Standout
Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology
2005 Standout
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
2009 Standout
Exercise Standards for Testing and Training
2013 Standout
Clinical and arteriographic characterization of patients with unstable angina without critical coronary arterial narrowing (from the TIMI-IIIA trial)
1994
Salutary effect of disopyramide on left ventricular diastolic function in hypertrophic obstructive cardiomyopathy
1995
Uric Acid and Cardiovascular Risk
2008 Standout
Myocardial ischemia-reperfusion injury: a neglected therapeutic target
2013 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling.
1998 StandoutNobel
Gout
2009 Standout
Sympathetic hyperactivity in chronic kidney disease: Pathogenesis, clinical relevance, and treatment
2004
ACC/AHA 2002 Guideline Update for Exercise Testing: Summary Article
2002 Standout
A causal role for uric acid in fructose-induced metabolic syndrome
2005
Antioxidants and Atherosclerotic Heart Disease
1997 Standout
Important role of endogenous norepinephrine and epinephrine in the development of in vivo pressure-overload cardiac hypertrophy
2001
Endothelial dysfunction: Clinical implications
1997
Role of mechanical and hormonal factors in cardiac remodeling and the biologic limits of myocardial adaptation
1993
Interaction of Cardiovascular Risk Factors with Myocardial Ischemia/Reperfusion Injury, Preconditioning, and Postconditioning
2007
Myocarditis
2011 Standout
Geometric and muscle physiological determinants of cardiac stroke volume as evaluated on the basis of model calculations
1988
Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy
2013 Standout
Evidence of Impaired Endothelium-Dependent Coronary Vasodilatation in Patients with Angina Pectoris and Normal Coronary Angiograms
1993
The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
1996 Standout
Hypertrophic Cardiomyopathy
2002 Standout
The influence of pretreatment lew density lipoprotein cholesterol concentrations on the effect of hypocholesterolemic therapy on coronary atherosclerosis in angiographic trials
1995
Association of carotid atherosclerosis and left ventricular hypertrophy
1995
Seven-transmembrane-spanning receptors and heart function
2002 StandoutNatureNobel
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial
2004 Standout
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
1999 Standout
Angina pectoris caused by coronary microvascular spasm
1998
Expert consensus document on arterial stiffness: methodological issues and clinical applications
2006 Standout
Biomarkers in Heart Failure
2008 Standout
Long-term prognosis of patients with anginalike chest pain and normal coronary angiographic findings
1995
Adipose Tissue as an Endocrine Organ
2004 Standout
Differential Impact of Blood Pressure–Lowering Drugs on Central Aortic Pressure and Clinical Outcomes
2006 Standout
Incremental Value of Pulse Wave Velocity in the Determination of Coronary Microcirculatory Dysfunction in Never-treated Patients With Essential Hypertension
2008
Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness
2010 Standout
Intracellular calcium, currents, and stimulus-response coupling in endothelial cells.
1993
Long-Term Follow-Up of Patients With Mild Coronary Artery Disease and Endothelial Dysfunction
2000 Standout
Fibrosis, not cell size, delineates β-myosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivo
2006 StandoutNobel
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting Stents
2005 Standout
Role of Endothelial Dysfunction in Atherosclerosis
2004 Standout
Arterial Stiffness and Cardiovascular Events
2010 Standout
Vitamin E reverses cholesterol-induced endothelial dysfunction in the rabbit coronary circulation
1994
Endothelial Dysfunction
2003 Standout
Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications.
1990 Standout
Acute Cholesterol Responses to Mental Stress and Change in Posture
1992
Myocardial Perfusion During Long-Term Angiotensin-Converting Enzyme Inhibition or β-Blockade in Patients With Essential Hypertension
2004
Air Pollution and Cardiovascular Disease
2004 Standout
Decreased Coronary Flow Reserve in Hypertrophic Cardiomyopathy Is Related to Remodeling of the Coronary Microcirculation
1998
Prognostic Impact of Coronary Vasodilator Dysfunction on Adverse Long-Term Outcome of Coronary Heart Disease
2000 Standout
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Arterial Wall Hypertrophy and Stiffness in Essential Hypertensive Patients
1995
Effect of Antihypertensive Treatment on Small Arteries of Patients With Previously Untreated Essential Hypertension
1995
Forecasting the Future of Cardiovascular Disease in the United States
2011 Standout
Impaired Endothelium-Dependent Vasodilation of Coronary Resistance Vessels Is Associated With Exercise-Induced Myocardial Ischemia
1995
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Impact of Psychological Factors on the Pathogenesis of Cardiovascular Disease and Implications for Therapy
1999 Standout
Chronic Inhibition of Nitric Oxide Synthesis Causes Coronary Microvascular Remodeling in Rats
1995
Silent Cerebral Infarcts in Patients With Pulmonary Embolism and a Patent Foramen Ovale
2009
Serum Carboxy-Terminal Propeptide of Procollagen Type I Is a Marker of Myocardial Fibrosis in Hypertensive Heart Disease
2000
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Mechanisms of Diabetic Complications
2013 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
2008 Standout
Molecular Mechanisms of Myocardial Remodeling
1999 Standout
Diabetic Cardiomyopathy: Evidence, Mechanisms, and Therapeutic Implications
2004
Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure
2000 Standout
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Relation of Exercise-Induced Myocardial Ischemia to Cardiac and Carotid Structure
1997
Flow-mediated endothelial mechanotransduction
1995 Standout
Myocardial Phosphocreatine-to-ATP Ratio Is a Predictor of Mortality in Patients With Dilated Cardiomyopathy
1997
Works of M. Vogt being referenced
Blood rheology as a contributing factor in reduced coronary reserve in systemic hypertension
1990
Response off hypertensive left ventricular hypertrophy and coronary microvascular disease to calcium antagonists
1995
Evidence of endothelial dysfunction in coronary resistance vessels in patients with angina pectoris and normal coronary angiograms
1991
Verbesserung der Koronarreserve nach Hypertrophieregression durch blutdrucksenkende Therapie mit einem β-Rezeptorenblocker*
2008
Left ventricular mass is linked to cardiac noradrenaline in normotensive and hypertensive patients
1996
Coronary haemodynamics in hypertensive heart disease
1992
Reduced peripheral and coronary vasomotion in systemic hypertension
1992
Disorders of coronary microcirculation and arrhythmias in systemic arterial hypertension
1990
Pathophysiology and clinical aspects of hypertensive hypertrophy
1993
Chronic cardiac reactions. I. Assessment of ventricular and myocardial work capacity in the hypertrophied and dilated ventricle
1987
Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension.
1993
Impaired Coronary Flow Reserve in NIDDM: A Possible Role for Diabetic Cardiopathy in Humans
1997
Myocardial and ventricular mechanics as influenced by disopyramide.
1986
[Long-term antihypertensive therapy with isradipine. Improvement of coronary flow reserve in patients with arterial hypertension and microvascular angina].
1994
Coronary Vascular Changes in the Progression and Regression of Hypertensive Heart Disease
1991